Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe −/− mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe −/− mice

Published:2012-05-18 Issue:8 Volume:55 Page:2267-2275
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Vittone F.,Liberman A.,Vasic D.,Ostertag R.,Esser M.,Walcher D.,Ludwig A.,Marx N.,Burgmaier M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-012-2582-5.pdf

Reference38 articles.

1. Pratley RE, Salsali A (2007) Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes. Curr Med Res Opin 23:919–931

2. Nystrom T, Gutniak MK, Zhang Q et al (2004) Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab 287:E1209–E1215

3. Kim Chung le T, Hosaka T, Yoshida M et al (2009) Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression. Biochem Biophys Res Commun 390:613–618

4. Dozier KC, Cureton EL, Kwan RO, Curran B, Sadjadi J, Victorino GP (2009) Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation. Peptides 30:1735–1741

5. Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM (2005) Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 54:146–151

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological therapy targeting the immune response in atherosclerosis;International Immunopharmacology;2024-11

2. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

3. Obesity, cardiovascular and cerebrovascular disease: the role of GLP-1 receptor agonists;Polish Archives of Internal Medicine;2024-01-09

4. The Potential for Multi-Disease Treatment: Applications of Dipeptidyl Peptidase Inhibitors;Advances in Clinical Medicine;2024

5. Characteristics of metabolic inflammatory syndrome among inpatients with type 2 diabetes: A cross-sectional study in China;Primary Care Diabetes;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3